Skip to main content
Premium Trial:

Request an Annual Quote

GenomeQuest Launches Grant Program to Help Labs Transition Sanger-Based Tests to Next-Gen Sequencing

Premium

GenomeQuest has kicked off an award proram that will provide bioinformatics support to five labs that want to consolidate multiple Sanger-based diagnostic tests into one next-gen sequencing-based test.

Labs that are awarded the grants, which the company values at $20,000 each, will receive all the software, annotation data, and compute infrastructure required to process and store patient sequence data, produce tailored diagnostic reports, and perform follow-up research on aggregated results, according to the company.

To qualify for the grant, labs must operate a medical diagnostic lab that is listed under the National Center for Biotechnology Information's GeneTests website and also be committed to transitioning to NGS-based testing.

In an announcement on its website outlining the program, GenomeQuest cites as an example the University of Iowa, which has consolidated more than 20 Sanger-based deafness tests into one NGS-based test. The switch has reduced the total cost of molecular diagnosis from $75,000 to under $2,000, GenomeQuest said.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.